AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2016

Mar 16, 2016

32870_dirs_2016-03-16_7591a2e8-dbd3-4790-813c-5a3642136a4d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-03-14

Reporting Person: Hauer Jerome M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-14	Common Stock	S	2350	$33.88	Disposed	14100	Direct

Footnotes

F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.83 to $33.93, inclusive.